BOSTON BUSINESS JOURNAL | A local company could soon have one of the first of a whole new class of medicines on the market that treat disease by rebalancing gut bacteria.
Toggle navigation
Toggle navigation
BOSTON BUSINESS JOURNAL | A local company could soon have one of the first of a whole new class of medicines on the market that treat disease by rebalancing gut bacteria.